HIV prevalence remains low among Calgary's needle exchange program participants

Canadian Journal of Public Health

Volumn 91, Issue 2, 2000, Pages 129-132

  Guenter, C Dale ^a   Fonseca, Kevin ^b   Nielsen, Diane M ^b   Wheeler, Virginia J ^b   Pim, Carolyn P ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABORIGINE; ADULT; ARTICLE; CANADA; DRUG DEPENDENCE; FEMALE; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEEDLE; RISK; SALIVA; SEXUAL BEHAVIOR;

EID: 0034040018     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03404928     Document Type: Article

References (10)

1. National Task Force on HIV and Injection Drug Use. HIV, AIDS and Injection Drug Use. A National Action Plan. Ottawa: Canadian Centre of Substance Abuse and the Canadian Public Health Association, 1997.
2. 'Safeworks' Injection Drug Use Education and Prevention Program. Evaluation Report for 1998. Calgary: Calgary Regional Health Authority, 1998.
3. Archibald CP, Remis RS, Farley J, Sutherland D. Estimating HIV prevalence and incidence at the national level: Combining direct and indirect methods with the Monte-Carlo simulation. Bureau of HIV/AIDS and STD, Health Canada, March 31, 1998.
4. Elnitsky S, Abernathy T. Calgary's needle exchange program: Profile of injection drug users. Can J Public Health 1993;84:177-80.
5. Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS 1997;11:F9-F65.
6. Bruneau J, Lamothe F, Franco E, et al. High rate of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study. Am J Epidemiol 1997;146:994-1002.
7. Frerichs RR, Siarug N, Eskes N, et al. Saliva-based antibody testing in Thailand. AIDS 1994;8:885-94.
8. Gallo D, George RJ, Fitchen JH, et al. Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. JAMA 1997;277:254-58.
9. Fonseca K, Anand CM. Predicting Human Immunodeficiency Virus Type 1-Positive sera by using two enzyme immunoassay kits in a parallel testing format. J Clin Microbiol 1991;29:2507-12.
10. Jacobs P, Calder P, Taylor M, et al. Cost effectiveness of Streetworks' Needle Exchange Program of Edmonton. Can J Public Health 1999;90:168-71.